Emerging Portfolio Medical Lead

About the role

AstraZeneca is hiring an Emerging Portfolio Medical Lead, an internal and external-facing medical role that provides medical and clinical expertise in emerging portfolio areas and builds AZ scientific leadership. The role sets the strategic direction for incorporating emerging products by bringing together cross-functional partners on the rollout of New Molecular Entities (NMEs) and Line Extensions (LEs) across cardiovascular, rare disease and oncology, and works with Oncology, Biopharm SMM and Alexion COM on clinical trial input.

Key responsibilities

• Act as medical expert on clinical development and local commercialization decisions, and take charge of newly introduced disease areas where AZ Korea has no coverage.
• Keep up to date on the science of new therapeutic areas and compounds.
• Provide medical input on study protocols, feasibility and site selection, and contribute to scientific presentations and site visits during clinical trials.
• Explore real-world data and evidence, develop a strategy for local RWD/RWE generation and generate it from medical databases or partnerships.
• Work with commercial, regulatory and market access teams on data requirements for registration, access and reimbursement.
• Build external collaborations with key opinion leaders, investigators, scientific associations and partners, and provide local medical expertise to regional and global teams.
• Deliver medical and clinical training to internal colleagues and anticipate future market trends.
• Ensure compliance with AZ SOPs, cGCP, the IFPMA code, pharmacovigilance requirements and the Code of Conduct, and report breaches.
• Monitor compliance of team members and third parties and foster an open culture of raising concerns.

Required profile

• Master's or doctoral degree (MD, PharmD or PhD) in a medical or scientific discipline.
• More than 7 years of experience in clinical practice, medical affairs and/or clinical operations.
• Fluency in English and ability to travel.
• Desirable: a medical degree with specialization, extensive knowledge of clinical development and regulatory developments, and experience leading launch strategies in CVRM, R&I, oncology or rare disease.